US Patent

US11969544 — Inhalers and airflow adaptors therefor

Formulation · Assigned to Norton Waterford Ltd · Expires 2039-08-20 · 13y remaining

Vulnerability score 55/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects an inhaler design that allows for the efficient transmission of air and powder medication to a patient.

USPTO Abstract

The present disclosure describes an inhaler for the inhalation of powder medication. The inhaler has a body and at least one reservoir containing powder medication, the body having an air inlet and an outlet for the transmission to a patient of air entering the body through the air inlet and powder medication. The outlet has a total cross-sectional area for flow which is more than 80% of the total cross-sectional area of the air inlet.

Drugs covered by this patent

Patent Metadata

Patent number
US11969544
Jurisdiction
US
Classification
Formulation
Expires
2039-08-20
Drug substance claim
No
Drug product claim
Yes
Assignee
Norton Waterford Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.